As expected, the specific activation of Beclin‐1, either genetically or pharmacologically, significantly improved cardiac performance under the challenge by LPS,27 leading us to postulate that the targeted activation of autophagy factors is an effective approach to boost adaptive autophagic responses, and thus, improves outcomes in sepsis. The gene discussed is BECN1; the disease is Sepsis.